Ophthotech Corporation(OPHT)- NASDAQ
From other sites
Company Description
Ophthotech Corp. operates as a biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the back of the eye. It develops therapies for age-related macular degeneration. Its product candidates include Fovista Anti platelet... More
Sector: Healthcare
Industry: Biotechnology
Country: United States